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Abstract
Bromodomain-containing protein 4 (Brd4) contains two tandem bromodomains (BD1 and BD2) that
bind preferentially to acetylated lysine residues found in histones and nonhistone proteins. This
molecular recognition allows Brd4 to associate with acetylated chromatin throughout the cell cycle
and regulates transcription at targeted loci. Recruitment of positive transcription elongation factor b,
and possibly the general initiation cofactor Mediator as well, plays an important role in Brd4-regulated
transcription. Selective contacts with acetyl-lysines in nucleosomal histones and chromatin-binding
factors likely provide a molecular switch modulating the steps from chromatin targeting to
transcriptional regulation, thus further expanding the ‘acetylation code’ for combinatorial regulation
in eukaryotes.
Introduction and context
Bromodomain-containing protein 4 (Brd4), originally
named MCAP (mitotic chromosome-associated protein)
[1], belongs to a family of proteins with two amino-
terminal tandem bromodomains (BD1 and BD2) and an
extraterminal (ET) domain located either at its central
region (for the longer isoform or family members) or
close to the carboxyl terminus (for the shorter isoform or
family members) (Figure 1). In addition to these three
evolutionarily conserved domains, bromodomain-ET
(BET) family proteins also contain other conserved
regions [i.e., A, B, SEED (Ser/Glu/Asp-rich region), and
carboxyl-terminal motif (CTM)] that are found in most
but not all members and have mostly uncharacterized
functions [2,3]. A unique feature of the BET proteins,
which include yeast bromodomain factor 1 (Bdf1),
bromodomain factor 2 (Bdf2), Drosophila female sterile
homeotic (Fsh), and mammalian (e.g., human and
mouse) Brd2, Brd3, Brd4, and testes/oocyte (i.e, germ
cell)-specific Brdt (Figure 1), is their persistent associa-
tion not only with interphase chromatin but also
with mitotic chromosomes [4-7]. The association with
mitotic chromosomes, also found for zebrafish and
Xenopus Brd4 even before fish zygotic transcription is
initiated [8], provides molecular marking for ensuing
gene expression coinciding with or immediately follow-
ing cell division [9-11].
Transcription-coupled mitotic control is likewise seen in
viral systems. Several virus-encoded proteins, such as E2
transcription/replication factor encoded by BPV-1
(bovine papillomavirus type 1) and human papilloma-
viruses (HPVs), bind Brd4 directly to facilitate selective
types of viral genome segregation during mitosis [12-15]
and to generally regulate viral gene transcription during
interphase [16-21]. Targeting cellular chromatin via
direct association with a BET family protein seems to
be widely used by other DNA tumor viruses for tethering
viral genomes and exerting a dominant effect on viral
and cellular gene expression [22-26]. Although viral
genome partitioning also occurs through mitotic spin-
dles/microtubules or specific regions of mitotic chromo-
somes in a Brd4-independent manner [27-29],
attachment of viral genomes to cellular chromatin
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transcription-coupled genome dynamics to be regulated
throughout the entire cell cycle.
Two ubiquitous transcription cofactors have been impli-
cated in Brd4-mediated gene regulation (Figure 2). The
general initiation cofactor Mediator (reviewed in [30])
was first identified by proteomic analysis of mouse Brd4
complexes [31] and later shown to associate with human
Brd4 independently of the cyclin-dependent kinase 8
(Cdk8) module [3]. That Brd4 is not found in human
transcription factor II D (TFIID) and is only detectable in
some forms of human Mediator complexes [3] suggests
that Brd4 has a unique role in the initiation of
transcription that is yet to be elucidated. The other
Brd4-associated general cofactor is positive transcription
elongation factor b (P-TEFb) [31,32], a dimeric protein
kinase consisting of Cdk9 and Cyclin T1 (or T2) that
facilitates RNA polymerase II (Pol II)-dependent tran-
scription through elongation blocks or pausing sites via
phosphorylation at serine 2 (Ser2) of the carboxyl-
terminal domain (CTD) in the largest subunit (RPB1) of
Pol II (reviewed in [33-35]). Brd4 association with
P-TEFb represents the active complex without the
inhibitory components HEXIM1/2 and 7SK small
nuclear RNA. How Brd4 transits from chromatin target-
ing to transcriptional regulation in response to environ-
mental cues is a crucial issue for our understanding of
epigenetic control in eukaryotic transcription.
Major recent advances
Acetylation of histone H3 lysine 14 (H3K14ac) and H4
dual lysines – either K5 and K12, or K8 and K16 – seems
to be crucial for Brd4 binding to acetylated histone
peptides in vitro [5]. Whether the bromodomains of Brd4
also interact with acetyl-lysine in a nonhistone protein
has recently been addressed by the identification of Brd4
as a bromodomain-containing protein that interacts with
the RelA subunit of nuclear factor (NF)kBi na n
acetylation-dependent manner [36]. Both bromodo-
mains of Brd4 are necessary for interacting with K310-
acetylated RelA and for tumor necrosis factor (TNF)a-
induced transcription of selective NFkB target genes, such
as those encoding E-selectin and TNFa, but not A20. It is
likely that association with acetylated RelA enhances the
interaction between Brd4 and acetylated histone H3 and
H4, which appears to be intrinsically weak and thus
requires cooperative binding through multiple protein-
protein (Brd4-activator and Brd4-histone) and protein-
DNA (activator-DNA) interactions [3]. This represents
the commitment step for Brd4-regulated target gene
transcription mediated by a transcriptional activator
(Figure 2, left). Although subsequent recruitment of
Mediator by Brd4 is likely necessary for Pol II entry to
the promoter region and ensuing CTD phosphorylation
(Figure 2, center), it is presently unknown how this
step occurs in the context of chromatin. Very often,
Pol II remains bound at the promoter region in an
inactive state until stress-induced signals reactivate its
elongation activity, allowing Pol II to pass through the
pausing site.
A broader role of Brd4 in transcriptional regulation has
likewise been addressed by knockdown studies and also
with gene profiling and chromatin immunoprecipitation
(ChIP) analysis of a large set of stress response genes and
their chromatin marks. Zhou and colleagues [9] demon-
strated that Brd4-mediated recruitment of P-TEFb to
selective G1 genes encoding JunB, c-Myc, Cdk7, and
Cyclin D1 begins in mid- and late anaphase, but prior to
nuclear envelope formation and the entry of Pol II, TFIIB,
and TFIIF, and continues into early G1 phase of the cell
cycle. Interestingly, Brd4 association with mitotic chro-
mosomes can occur at different stages of mitosis,
depending on the cell type, and seems to be regulated
by undefined cellular factors or covalent modifications.
This mitotic association of selective G1 genes has been
Figure 1. Domain organization of the bromodomain and
extraterminal domain (BET) family proteins
The evolutionarily conserved domains found in bromodomain-containing
protein 4 (Brd4) and the other BET family proteins include bromodomain 1
(BD1), bromodomain 2 (BD2), extraterminal (ET), motif B, and SEED (Ser/
Glu/Asp-rich region). Motif A and the carboxyl-terminal motif (CTM) are
present only in some family members. Numbers indicate the amino acid
boundaries of each protein derived from human (h), Drosophila (d), or yeast
(y). The short form of human Brd4 (hBrd4) is also shown for comparison.
Alignment of amino acid sequences and the accession number for each
protein-coding gene are based on the information described by Wu and
Chiang [3]. Bdf, bromodomain factor; Fsh, female sterile homeotic.
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elegantly illustrated by microarray analysis and quanti-
tative RT-PCR (reverse transcription polymerase chain
reaction) that many G1 gene products, including Cyclin
D1, D2, E1, and E2, and phosphorylation of pRb, are
downregulated in Brd4-knockdown NIH3T3 cells and
mouse embryonic fibroblasts [10], and that Brd4
marking of M/G1 genes increases significantly at
telophase, coinciding with increased acetylation of
histone H3 and H4 in these genes as well as P-TEFb
recruitment and de novo M/G1 gene transcription [11].
The general significance of Brd4-recruited P-TEFb has
been further revealed by another study using ChIP
analysis of many primary response genes showing that,
upon lipopolysaccharide stimulation of Toll-like
receptor signaling, paused Pol II with Ser5 phosphory-
lation promptly resumes elongation following Ser2
phosphorylation of its CTD that is mediated by
P-TEFb, which is recruited by Brd4 via recognition of
induced acetylation at histone H4K5/8/12 in most
primary response gene promoters [37]. Nevertheless, an
independent study performed on the FOSL1 gene, which
encodes the Fra1 subunit of AP-1 complexes, reported
that MOF (males absent on the first)-acetylated H4K16
triggered by serum-induced PIM1 phosphorylation of
H3 serine 10 (H3S10ph) are both required for Brd4
binding to targeted chromatin, which in turn recruits
P-TEFb to the FOSL1 gene [38]. P-TEFb then induces Ser2
phosphorylation, which reactivates Pol II elongation
activity (Figure 2, right). It appears that H3K9ac is
needed for efficient H3S10ph to occur. While both
reports clearly indicate the importance of Brd4 in
recruiting P-TEFb to poised Pol II in stress-induced
gene activation, the nature of modified histone tails
involved in the recruitment of Brd4 – that is, acetylated
Figure 2. Acetylation of histone H3 and H4 lysine residues modulates Brd4 association with chromatin and the recruitment





































Three steps for bromodomain-containing protein 4 (Brd4)-regulated chromatin targeting and transcriptional regulation are highlighted. The first step (left)
represents a commitment to target gene transcription illustrated by cooperative binding between Brd4 and a transcriptional activator with acetylated
chromatin through Brd4-activator interaction, activator-DNA contact, and Brd4 association, via its tandem bromodomains, with acetylated lysine 5 (K5ac),
acetylated lysine 8 (K8ac), acetylated lysine 12 (K12ac), and acetylated lysine 16 (K16ac) of histone H4, and/or acetylated lysine 14 (K14ac) of histone H3. The
second step (center) is Brd4-mediated recruitment of the initiation cofactor Mediator to the promoter region, which often leads to phosphorylation of the
RNA polymerase II (Pol II) carboxyl-terminal domain (CTD) at Ser5 during initiation and post-initiation events. The third step (right) is Brd4-facilitated
recruitment of the elongation cofactor P-TEFb (positive transcription elongation factor b) to paused Pol II that results in Ser2 phosphorylation of the CTD,
thereby allowing Pol II to resume elongation. The inducible recruitment of Brd4 to an acetylated nucleosome located downstream of the transcription start
site (indicated by an arrow) appears to depend on crosstalk between acetylated lysine 9 (K9ac) and phosphorylated serine 10 (S10) of H3 with H4K16ac [38].
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different. This is possibly due to dynamic binding of
different histone acetyltransferases (HATs) and histone
deacetylases (HDACs) surrounding the targeted loci at
the time of induction. A recent genome-wide binding
survey of five HATs [p300, CREB-binding protein (CBP),
p300/CBP-associated factor (PCAF), MOF, and Tip60]
and four HDACs (HDAC1, HDAC2, HDAC3, and
HDAC6) by high-throughput sequencing of antibody-
pulled down ChIP fragments (ChIP-Seq) isolated from
resting and induced primary human CD4
+ T cells
surprisingly revealed that both HATs and HDACs co-
reside in most active genes and also in many repressed
but inducible genes [39]. Since H3K9/14 and H4K5/8/
12/16 can be acetylated by various HATs (p300/CBP for
H3K14 and H4K5/8, PCAF for H3K9/14, Tip60 for
H3K14 and H4K5/8/12/16, and MOF for H4K16)
(reviewed in [40,41]), the distinct patterns of acetylated
residues identified in Brd4 recruitment probably reflect
specific HATs and HDACs available in the surveyed cell
types and the induced signaling pathways. This intri-
guing possibility needs to be explored in the future.
Brd4-mediated recruitment of P-TEFb is also important
for transcription of viral promoters, as recently demon-
strated in several HPV-harboring human cell lines, in
which HPV-encoded E2 protein is able to suppress viral
transcription by displacing P-TEFb from Brd4-bound
HPV chromatin owing to competition between high-
affinity E2 and low-affinity P-TEFb for the same binding
site at the CTM of Brd4 [42]. This result provides an
additional mechanism for the E2-Brd4 silencing complex
that efficiently inhibits HPV chromatin transcription by
blocking TFIID and Pol II recruitment to the viral
promoter in a bromodomain-dependent manner [16].
In HPV it is likely that both Brd4-regulated initiation and
elongation steps of transcription are simultaneously
targeted by E2 for efficient suppression of viral gene
expression, consistent with a central role of Brd4 in both
cellular and viral gene transcription.
Recent structural determination of several BET bromo-
domains further provides atomic details for bromodo-
main/acetyl-lysine interactions. While an earlier study
reporting that homodimer formation of BD1 derived
from human Brd2 creates a negatively charged secondary
binding pocket at the dimer interface may help to
determine binding specificity provided by the acetyl-
lysine-binding pocket of BD1 [43], dimerization of
mouse Brd4 BD1 or BD2 was not seen in solution or
in crystal structures [44]. Both BD1 and BD2 of mouse
Brd4 exhibit the classical bromodomain fold consist-
ing of four a-helices (aZ, aA, aB, and aC) and two
interconnecting ZA and BC loops. Charged amino acid
residues (acidic in BD2, basic in BD1) surrounding the
acetyl-lysine-binding pocket may enhance the binding
specificity of BD1 and BD2. An amino-terminal exten-
sion of BD1 that helps stabilize the bromodomain fold is
also evident in the structure. It is noted that the binding
affinities of BD2 for K390-acetylated Cyclin T1 peptide
and H4K5ac or H4K16ac peptide are rather similar
(Kd ~110 mM), indicating the possibility of switching of
BD2 binding from acetylated chromatin to acetylated
P-TEFb [44].Aspredicted[3],cooperativebindingbetween
Brd4 and a DNA-binding factor is generally required to
stabilize Brd4 association with chromatin, as now
shown by the low affinity measured for the interaction
between BD1/BD2 and acetylated histone tails, which
is mediated by a few hydrogen bonds and sparse
hydrophobic contacts [44].
The cooperative nature of bromodomain binding to
acetyl-lysine has also been demonstrated by isothermal
calorimetry measuring differences in the binding affi-
nities of BD1 and BD2 of mouse Brdt for histone H3 and
H4 peptides with varying degrees of acetylation at
distinct lysine residues [45]. Surprisingly, BD2 fails to
bind tetra- and mono-acetylated H4 peptides, whereas
BD1 binds as efficiently as an amino-terminal portion of
Brdt protein containing both BD1 and BD2 to tetra-
acetylated H4 peptide (Kd ~28.0 mM). Clearly, BD1 and
BD2 are not equivalent binders and each has unique
features and binding affinities for acetyl-lysine residues
in both histones and nonhistone proteins. A compilation
of binding studies performed with various BET proteins
or their derived bromodomains and acetylated lysines in
histone H3 and H4 at different positions is summarized
in Figure 3. Clearly, cooperative binding to acetylated
histone tails requires diacetylated lysines with properly
spaced residues. A crystal structure of mouse Brdt BD1 in
complex with diacetylated H4K5acK8ac peptide revealed
an unexpected association of two acetylation marks on
the same histone tail with a single bromodomain [45].
BD1 binding to K5ac is prototypical and K8ac-BD1
interaction is mediated primarily through hydrophobic
contacts, mimicking overall a two-pronged plug with
K5ac inserted deep into the acetyl-lysine-binding pocket
and K8ac bent diagonally towards K5ac. The structure of
BD1 binding to the diacetylated K5ac-GG-K8ac peptide
seems to be conserved among several other bromodo-
mains, although these are yet to be experimentally
illustrated.
Future directions
Recent structural determination and functional assays
from both gene/domain-based and global approaches
have shed light on the cooperative nature of interactions
between the bromodomains of BET family proteins and
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recognition of acetylated lysine residues in histone H3
and H4 at distinct positions likely reflects the transition
from chromatin targeting to transcriptional regulation
and the need to break and reform the contact between
two tandem bromodomains and acetyl-lysine residues.
Elucidation of the combinatorial usage of acetylation
codes at different stages of chromatin binding and
transcriptional events will need to be conducted in a
variety of cell types under both unstressed and stressed
conditions in the future. The complexity of cellular
environments also points to the need for applying well-
defined reconstitution systems to elucidate the molecu-
lar and biochemical pathways leading to differential
utilization of different BET family proteins in chromatin
targeting and gene regulation. While the functional
analysis of Brd4-regulated P-TEFb recruitment in diverse
gene responses represents a continuing interest for future
studies, the role of Mediator and its mechanistic
involvement in BET-mediated transcription needs to be
established. The biological effects of protein domains in
BET family members other than the two bromodomains
also require detailed characterization. Without doubt,
the identification of chromatin adaptors implicated in
transcriptional regulation and the elucidation of the
acetylation code warrant continuing efforts for future
investigations.
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